1 – 15 of 40
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity
(
- Contribution to journal › Article
- 2022
-
Mark
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
(
- Contribution to journal › Article
- 2021
-
Mark
Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
(
- Contribution to journal › Article
-
Mark
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
(
- Contribution to journal › Article
- 2018
-
Mark
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
(
- Contribution to journal › Article
- 2017
-
Mark
Venous thromboembolism and cancer risk
(
- Contribution to journal › Article
-
Mark
Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR
(
- Contribution to journal › Article
-
Mark
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis
(
- Contribution to journal › Article
-
Mark
Safety and Efficacy of Bridging with Low-Molecular-Weight Heparin during Temporary Interruptions of Warfarin : A Register-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia
(
- Contribution to journal › Article
-
Mark
Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves : A Swedish cohort study
(
- Contribution to journal › Article
-
Mark
Non-Vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin : A retrospective register study
(
- Contribution to journal › Article
-
Mark
No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia : A population-based study in Sweden
(
- Contribution to journal › Letter
-
Mark
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
(
- Contribution to journal › Article
- 2016
-
Mark
Bleeding complications in venous thrombosis patients on well-managed warfarin.
(
- Contribution to journal › Article